Cargando…

Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification

BACKGROUND: This study aimed to characterize and differentiate the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy 2011 cut points through the modified Medical Research Council dyspnea scale (mMRC) and chronic obstructive pulmonary disease (COPD) assessment test (CAT). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Price, David B, Baker, Christine L, Zou, Kelly H, Higgins, Victoria S, Bailey, James T, Pike, James S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043424/ https://www.ncbi.nlm.nih.gov/pubmed/24920893 http://dx.doi.org/10.2147/COPD.S62104

Ejemplares similares

Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians
por: Price, David, et al.
Publicado: (2015)

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries
por: Davie, Alison, et al.
Publicado: (2020)

The World Health Network: a global citizens' initiative
por: Bar-Yam, Yaneer, et al.
Publicado: (2021)

Impact of night-time symptoms in COPD: a real-world study in five European countries
por: Price, David, et al.
Publicado: (2013)

Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System
por: Jones, Eddie, et al.
Publicado: (2021)

The Impact of Agitation in Dementia on Caregivers: A Real-World Survey
por: Schein, Jeff, et al.
Publicado: (2022)

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy
por: Bengtson, Lindsay G.S., et al.
Publicado: (2018)

Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK
por: Voorham, Jaco, et al.
Publicado: (2018)

Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH
por: Fishman, Jesse, et al.
Publicado: (2023)

Real-World Impact of Cardiovascular Disease and Anemia on Quality of Life and Productivity in Patients with Non-Dialysis-Dependent Chronic Kidney Disease
por: Covic, Adrian, et al.
Publicado: (2017)

Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015
por: Higgins, Victoria, et al.
Publicado: (2016)

1539. Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United States
por: Hennessy, Fritha, et al.
Publicado: (2023)

The Evaluation of Interstitial Abnormalities in Group B of the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classification of Chronic Obstructive Pulmonary Disease (COPD)
por: Ohgiya, Masahiro, et al.
Publicado: (2017)

Initial inhaler choice in COPD: real-world evidence
por: Jones, Thomas
Publicado: (2019)

Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification
por: Kostikas, Konstantinos, et al.
Publicado: (2023)

Real-world effectiveness of osteoporosis treatments in Germany
por: O’Kelly, James, et al.
Publicado: (2022)

Real-World Experience with Dolutegravir-Based Two-Drug Regimens
por: Ward, Douglas, et al.
Publicado: (2020)

Practical monitoring: effective strategies for the real world
por: Julian, Mike
Publicado: (2018)

Real‐World Data: An Unrealized Opportunity in Global Health?
por: Barrett, Jeffrey S., et al.
Publicado: (2019)

Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease
por: Halpern, Rachel, et al.
Publicado: (2011)

Strategies for Selecting Routes through Real-World Environments: Relative Topography, Initial Route Straightness, and Cardinal Direction
por: Brunyé, Tad T., et al.
Publicado: (2015)

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
por: Sikirica, Mirko V, et al.
Publicado: (2017)

The value of regional and global CACS combined with SPECT MPI in detecting obstructive CAD: a retrospective real-world comparative study
por: Jiang, Qi, et al.
Publicado: (2023)

Global Initiative for Chronic Obstructive Lung Disease: The Changes Made
por: Patel, Avani R, et al.
Publicado: (2019)

The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017
por: Menezes, Ana M, et al.
Publicado: (2017)

Real-World Impact of Physician and Patient Discordance on Health-Related Quality of Life in US Patients with Acute Myeloid Leukemia
por: Horvath Walsh, L. Elise, et al.
Publicado: (2019)

Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United States
por: Thach, Andrew, et al.
Publicado: (2021)

The Burden of Nocturnal Symptoms in Patients with Chronic Obstructive Pulmonary Disease: Results of a Real-World Survey in the USA
por: Soler, Xavier, et al.
Publicado: (2022)

Impact of Dementia-Related Behavioral Symptoms on Healthcare Resource Use and Caregiver Burden: Real-World Data from Europe and the United States
por: Chekani, Farid, et al.
Publicado: (2021)

Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
por: Thomann, Robert, et al.
Publicado: (2020)

Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions
por: Anstee, Quentin M., et al.
Publicado: (2021)

Risk assessment of readmissions following an initial COPD-related hospitalization
por: Baker, Christine L, et al.
Publicado: (2013)

Deep learning and alternative learning strategies for retrospective real-world clinical data
por: Chen, David, et al.
Publicado: (2019)

Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
por: Attardi, Enrico, et al.
Publicado: (2023)

Correction: Real-world effectiveness of osteoporosis treatments in Germany
por: O’Kelly, James, et al.
Publicado: (2022)

Impact of advanced Parkinson’s disease on caregivers: an international real-world study
por: Martinez-Martin, Pablo, et al.
Publicado: (2023)

Real-World Treatment Patterns and Costs for Patients with Renal Cell Carcinoma Initiating Treatment with Sunitinib and Pazopanib
por: MacLean, Elizabeth, et al.
Publicado: (2016)

Book Review: Safer Healthcare; Strategies for the Real World
por: Lintern, Gavan
Publicado: (2017)

Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence
por: Cuker, Adam, et al.
Publicado: (2023)

EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making
por: Plueschke, Kelly, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m13g0lj96drs3g8c0pe3pq2n24